MedTrace Logo

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

NCT03394105 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-03-08

No results posted yet for this study

Summary

In this trial, the effect of intrapleural docetaxel administration using medical pleuroscopywill be evaluated in Lung Cancer patient with malignant effusion.

Conditions

  • Pleural Effusion, Malignant
  • Non-small Cell Carcinoma

Interventions

DRUG

intrapleural docetaxel administration

intrapleural docetaxel administration using medical pleuroscopy in malignant effusion with lung cancer

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • CHANG-MIN CHOI, MD, PhD · Asan Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-26
Primary Completion
2018-06-22
Completion
2018-06-22

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394105 on ClinicalTrials.gov